Abstract:Objective To study the risk factors for embolism in children with refractory Mycoplasma pneumoniae pneumonia (RMPP) and to construct a nomogram model for prediction of embolism. Methods This retrospective study included 175 children diagnosed with RMPP at Children's Hospital Affiliated toZhengzhou University from January 2019 to October 2023. They were divided into two groups based on the presence of embolism: the embolism group (n=62) and the non-embolism group (n=113). Multivariate logistic regression analysis was used to screen for risk factors of embolism in children with RMPP, and the R software was applied to construct the nomogram model for prediction of embolism. Results Multivariate logistic regression analysis indicated that higher levels of D-dimer, interleukin-6 (IL-6) and neutrophil to lymphocyte ratio (NLR), lung necrosis, and pleural effusion were risk factors for embolism in children with RMPP (P<0.05). The area under the curve of the nomogram model for prediction of embolism constructed based on the aforementioned risk factors was 0.912 (95%CI: 0.871-0.952, P<0.05). The Hosmer-Lemeshow goodness-of-fit test showed that the model had a good fit with the actual situation (P<0.05). Calibration and decision curve analysis indicated that the model had high predictive efficacy and clinical applicability. Conclusions Higher levels of D-dimer, IL-6 and NLR, lung necrosis, and pleural effusion are risk factors for embolism in children with RMPP. The nomogram model based on these risk factors has high clinical value for predicting embolism in children with RMPP.
XIE Li-Na,FENG Te,GUO Yan-Jun et al. Risk factors for embolism in children with refractory Mycoplasmapneumoniae pneumonia and construction of a nomogram model for prediction of embolism[J]. CJCP, 2024, 26(5): 486-492.
Li M, Wei X, Zhang SS, et al. Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model[J]. BMC Pulm Med, 2023, 23(1): 383. PMID: 37817172. PMCID: PMC10566172. DOI: 10.1186/s12890-023-02684-1.
van Es N, Kraaijpoel N, Klok FA, et al. The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis[J]. J Thromb Haemost, 2017, 15(4): 678-684. PMID: 28106338. DOI: 10.1111/jth.13630.
Mirijello A, La Marca A, D'Errico MM, et al. Venous thromboembolism during Mycoplasma pneumoniae infection: case report and review of the literature[J]. Eur Rev Med Pharmacol Sci, 2020, 24(19): 10061-10068. PMID: 33090413.DOI: 10.26355/eurrev_202010_23223.
Han C, Zhang T, Zheng J, et al. Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study[J]. Ital J Pediatr, 2022, 48(1): 153. PMID: 35987653. PMCID: PMC9391649. DOI: 10.1186/s13052-022-01344-0.
Xing H, Liu X, Li A, et al. Increased peripheral TFH cells and serum interleukin-21 in childhood Mycoplasma pneumoniae pneumonia[J]. J Coll Physicians Surg Pak, 2021, 30(5): 605-607. PMID: 34027881. DOI: 10.29271/jcpsp.2021.05.605.
Sharma DJ Sr, Nath HJ, Batta A, et al. Neutrophil-to-lymphocyte ratio (NLR) useful as a cost-effective preliminary prognostic marker in ST-elevation myocardial infarction (STEMI): an observational study from a tertiary care hospital in Northeast India[J]. Cureus, 2023, 15(3): e36885. PMID: 37128536. PMCID: PMC10147565. DOI: 10.7759/cureus.36885.
Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases[J]. Int J Mol Sci, 2022, 23(7): 3636. PMID: 35408994. PMCID: PMC8998851. DOI: 10.3390/ijms23073636.
Ling Y, Ning J, Xu Y. Explore the predictive value of peripheral blood cell parameters in refractory Mycoplasma pneumoniae pneumonia in children over 6 years old[J]. Front Pediatr, 2021, 9: 659677. PMID: 34869089. PMCID: PMC8633951. DOI: 10.3389/fped.2021.659677.
Mareev VY, Orlova YA, Pavlikova EP, et al. Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)[J]. Kardiologiia, 2020, 60(6): 15-29. PMID: 32720612. DOI: 10.18087/cardio.2020.6.n1226.